BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, March 28, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
April 28, 2006
View Archived Issues
Phase II studies show notable activity of sunitinib in metastatic renal cell carcinoma
Read More
NOX-F37: a Spiegelmer that targets AVP to evoke diuresis
Read More
Safetek to develop new selective muscarinic receptor antagonist for OAB
Read More
Isotechnika signs option agreement for topical delivery of ISA-247
Read More
Stem Cell Therapeutics enters agreement to support phase IIa study of NTx-265
Read More
Enrollment completed in confirmatory study of OrCel in venous leg ulcers
Read More
FivePrime and Boehringer Ingelheim team up in rheumatoid arthritis
Read More
Activity of phenserine tartate in Alzheimer's disease detailed in clinical trials
Read More
FAS-93: FAS-targeting antineoplastic strategy without associated anorexia
Read More
Phase I data presented on SLV-317
Read More
E.U. label change for Intron
Read More
First approvals for initiation of PrimoVax study of GV-1001
Read More
SPARC trial of satraplatin cleared to continue to completion
Read More
Novel MEK inhibitor ARRY-438162 begins phase I study
Read More
Orphan drug designation for Nexavar in hepatocellular carcinoma
Read More
New phase III study for AIR Inhaled Insulin System
Read More
Orathecin study fails to meet median survival threshold for advancement
Read More
Exforge NDA accepted for review
Read More
Japanese approval for lanoconazole for athlete's foot
Read More
New nuclear export inhibitor displays antitumor efficacy and a favorable therapeutic index
Read More
In vitro and in vivo profiling of GW-427353, a beta-3 adrenergic agonist clinical candidate
Read More
Cimzia MAA submitted in Europe for Crohn's disease
Read More
NDA submission for single-tablet regimen of Sustiva and Truvada
Read More
European CHMP hands down positive opinion for Nexavar in kidney cancer
Read More
Valeant discloses new therapeutic agents for HIV infection
Read More
New treatments for cancer covered in recent patents
Read More
Herceptin recommended for approval for early-stage breast cancer in Europe
Read More
U.K. approval for DepoDur in postoperative pain
Read More
New antiinfective agents the subject of recent patents
Read More
Epothilones with favorable pharmacological profiles a highlight at the AACR meeting
Read More